1.1Radiation initiates network formation
An electron beam irradiates a concentrated aqueous polyglutamate layer under nitrogen. Radiation generates radicals on the polymer chains, and coupling between those radicals forms a water-swellable network.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
An electron beam irradiates a concentrated aqueous polyglutamate layer under nitrogen. Radiation generates radicals on the polymer chains, and coupling between those radicals forms a water-swellable network.
A sealed ultrafiltration membrane pouch contains high-molecular-weight sodium polyglutamate. Water enters by osmosis and expands the pouch, while pores smaller than the hydrated polymer coils retain the dissolved chains.
The process forms the gel from a concentrated polymer mixture with less water than the finished network holds at equilibrium. A rotary cutter dices the wet gel, and a porous fiber layer distributes incoming fluid across the pieces so they can swell further.
A tumbler sprays the granules with dilute chitosan acetate solution. Protonated chitosan groups bind to polyglutamate carboxylates at the surface, forming a thin layer that improves wet particle integrity while the core takes up water.
A heated roll press compacts the dried particles into a thin sheet, which a mill breaks into granules. Compression increases particle contact and bulk density, while the existing crosslinked network retains its ability to swell in water.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
An aqueous polyglutamic acid salt mixture is crosslinked, dried, and heat treated in the presence of a facilitator. The treated polymer is granulated and packed into a permeable cellulose sachet with free volume for swelling. The sachet sits beneath the growing medium in a seedling tray and takes up irrigation water through its walls. Water moves from the swollen granules into the surrounding medium as the medium dries.
Ferric chloride replaces the organic crosslinker in an aqueous sodium polyglutamate formulation. A metering pump feeds dilute ferric chloride into the stirred polymer solution, where ferric ions coordinate carboxylate groups on different polymer chains to form a gel. The gel is cut into pieces and dried on trays. The dried pieces are contacted with a heat-treatment facilitator and heated.
An aqueous polyglutamic acid salt and crosslinker mixture is cast between 2 mm spacer rails and held until it forms a self-supporting gel sheet. The sheet is cut into 20 mm squares and placed in a single layer on a perforated dryer tray. Heated air passes over both faces of each square, with a maximum initial drying path of 1 mm from the center plane to a face. The dried squares are contacted with a facilitator and transferred to a separate heating chamber.
A crosslinked polyglutamic acid salt gel is dried, treated with heat in the presence of a facilitator, and milled into granules. A loss-in-weight feeder introduces the granules into a stream of opened cellulose fibers upstream of an airlay forming head. Vacuum beneath a perforated belt draws the fibers and granules onto a tissue carrier. A second tissue layer covers the core, and the line seals the edges before cutting individual veterinary bedding pads.
A perforated belt carries crosslinked polyglutamic acid salt gel pieces through a forced-air dryer. A near-infrared sensor at the discharge measures residual moisture using a calibration built from gravimetric measurements on the same formulation. A controller adjusts belt speed within preset limits and diverts material that exits above the moisture limit. Material within the moisture limit passes to a facilitator applicator and then to a separate heated zone.
A weigh belt measures the mass flow of dried polyglutamic acid salt granules, and a microwave moisture sensor estimates their water content. A controller calculates dry polymer mass flow and sets a metering pump to deliver a fixed mass of facilitator per unit mass of dry polymer. Spray nozzles apply the facilitator solution inside a rotating drum that tumbles the granules during dosing. The coated granules feed directly into a heated conveyor with a controlled residence time.
A stirred vessel dissolves sodium polyglutamate in water and disperses a water-soluble polyethylene glycol diglycidyl ether. Sodium hydroxide adjusts the mixture to alkaline pH for the subsequent crosslinking reaction.
A water-soluble carbodiimide activates a fraction of the polyglutamic acid carboxyl groups. Both ends of ethylenediamine react with activated groups on separate chains to form amide bridges and produce a gel.
A cutter divides the crosslinked gel into pieces and spreads them in a shallow bed on a perforated belt. Heated air passes through the bed and removes water until the pieces reach the specified residual moisture.
A mixer sprays a thin glycerol coating onto dried crosslinked granules that contain free carboxylic acid groups. Heating promotes ester formation between glycerol and those groups near the particle surface.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
For the application to tissue adhesion, a mixture containing the activated γ-polyglutamic acid derivatives and the polyethylene glycol polymers, for example, a mixture aqueous solution is formed on biological tissue and then, the thus formed aqueous solution is subject to crosslinking reaction to form a hydrogel, which can form coatings on the biological tissue.A · US 9,254,348 B2 · ¶ 91
At room temperature 4.0 g γ-polyglutamic acid (1 million to 1.2 million Daltons, including 0.031 mole of carboxyl groups) was dissolved in 50 ml of 0.1 mol/L MES buffer (pH 5.0), and stirred until a clear solution was formed.B · US 2017/0014543 A1 · ¶ 45
It has been elucidated that if at least some of γ-polyglutamic acid are activated to convert into succinimide ester groups by reaction with a certain compound, the thus activated γ-polyglutamic acid can quickly gelate (crosslinking reaction) with a polyethylene glycol based polymer having nucleophilic functional groups such as an amine group, thiol group or hydroxyl group at a room temperature to form a hydrogel.A · US 9,254,348 B2 · ¶ 27
(2) adding a cross-linking agent into the mixture obtained in step (1), reacting in an ice bath for 10 to 120 min, then reacting for 2 to 24 hours at room temperature to form said hydrogel;B · US 2017/0014543 A1 · claim 4
The hydrogels prepared by the above methods may be provided in forms of sponge or sheet, or powders by conducting lyophilization, and they may be employed in such forms for anti-adhesive agents, absorbents, drug delivery, etc.A · US 9,254,348 B2 · ¶ 91
The hydrogel formed was placed into a dialysis bag, and dialyzed in deionized water until swelling equilibrium, then freeze drying or vacuum drying was adopted to obtain a sponge-like dressing, swelling rate of the hydrogel formed was 96.6 g/g.B · US 2017/0014543 A1 · ¶ 45
An empty cell means only that no passage was reproduced there.
This invention relates to a biodegradable, biocompatible hydrogel, which can be used for sealants of suppressing the leakage of blood or air during surgical operation, tissue adhesives, anti-adhesive agents and drug delivery carriers, and a method for producing the same.A · US 9,254,348 B2 · ¶ 7
However, since the reaction conditions are 40° C. for 48 hours, or 90° C. for 30 min, it is impossible to apply it for the purpose of in situ gelation in medical fields.A · US 9,254,348 B2 · ¶ 13
Hydrogel dressing can effectively overcome above-described shortcomings, it has a good steam and gas permeability, it may not adhere to the wound, and easy to be replaced.B · US 2017/0014543 A1 · ¶ 4
In conclusion, for respective disclosures of preparation of hydrogel by using polyglutamic acid and polylysine as raw material, there are shortcomings such as poor biocompatibility of the cross-linking agent and complicated preparation steps.B · US 2017/0014543 A1 · ¶ 8
patent.fyi, US 2026/0355379 A1, claim 1, first published 2026-11-19T10:59:45-05:00, https://patent.fyi/US20260355379/, SHA-256 fbef654cda16a516c323e4a406784b7b0744142490266e28debe46ecf5b6d465